Organoid Model-based Research Services

Online Inquiry

Name *

Email *

Phone *

Services Or Products Interested *

Project Description

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Molecular Biology Research Services

Cancer molecular biology is a domain at the forefront of medical research. Understanding the precise pathways dysregulated in cancer cells is fundamental to developing effective preventive and therapeutic strategies. Specializing in high-fidelity 3D cancer model development, Alfa Cytology's team delivers comprehensive molecular biology research services designed to unravel the complexities of tumor progression, resistance mechanisms, and therapeutic responses. We provide end-to-end molecular profiling and custom analysis to elucidate disease mechanisms, identify biomarkers, and validate therapeutic targets within a highly physiologically relevant model system.

Overview of Molecular Biology Research

Molecular biology research is fundamental to understanding the complex genetic, epigenetic, and signaling aberrations that drive cancer initiation, progression, and therapy resistance. By integrating genomic, transcriptomic, and proteomic workflows, researchers can map the intricate signaling networks underlying tumorigenesis. Utilizing 3D models ensures that the molecular data captured reflects the spatial heterogeneity and cell-cell interactions of the native tumor microenvironment, thereby providing a context that surpasses the limitations of traditional 2D cell cultures.

Advanced Organoid Models for Molecular Biology Research

The molecular biology services are built upon a robust foundation of physiologically relevant 3D cancer organoid models. These patient-derived or cell line-derived avatars recapitulate the genomic, cellular, and architectural complexity of native tumors, providing an ideal platform for rigorous molecular dissection.

Types of Organoids	Description
Colorectal Cancer Organoids	Used to study APC, KRAS, and TP53 mutation-driven pathways, epithelial-stromal interactions, and mechanisms of chemoresistance (e.g., to 5-FU, oxaliplatin).
Breast Cancer Organoids	Employed for profiling molecular subtypes (ER/PR/HER2), analyzing PI3K/AKT/mTOR and ESR1 signaling, and investigating tumor microenvironment crosstalk.
Pancreatic Cancer Organoids	Applied to model aggressive KRAS and SMAD4-mutant disease, explore metabolic reprogramming, and test novel targeted and immunotherapeutic strategies.
Glioblastoma Organoids	Utilized to probe EGFR amplification, PTEN deletion, and MGMT methylation effects within a structured neural environment, assessing invasion and stem cell dynamics.
Non-Small Cell Lung Cancer (NSCLC) Organoids	Deployed for identifying actionable mutations (EGFR, ALK, ROS1), studying the evolution of resistance to TKIs, and characterizing tumor-immune interactions.

Applications of Molecular Biology Research

Integrating molecular biology with 3D organoid development technology enables a multifaceted approach to cancer research. Key applications include:

Drug Response & Resistance Profiling: Correlate genomic, transcriptomic, and proteomic changes with sensitivity or resistance to standard therapy and experimental therapeutics to define mechanisms of action and escape.
Tumor Heterogeneity Analysis: Map subclonal architecture and evolutionary trajectories within organoid populations using high-resolution sequencing, revealing drivers of intra-tumor diversity.
Pathway Activation & Target Validation: Systematically analyze key oncogenic signaling pathways (e.g., Wnt/β-catenin, Notch, RTK/RAS) to confirm target engagement and identify synthetic lethal interactions.
Tumor Microenvironment (TME) Interactions: Characterize gene expression and secretory profiles of cancer cells and co-cultured stromal/immune components to understand how the TME influences tumor behavior and therapy outcomes.

Our Services

Leveraging our deep expertise in 3D cancer model biology and state-of-the-art molecular platforms, Alfa Cytology delivers tailored research services. Our integrated approach ensures that molecular data is contextualized with functional phenotypic readouts from your organoid models, providing biologically actionable insights for decision-making.

Types of Cancer Organoid Development

To support a wide spectrum of molecular biology research inquiries, we provide development services for a diverse array of cancer organoid models. This includes models derived from multiple cancer types (carcinomas, gliomas, sarcomas), various biological sources, and different 3D culture formats (matrigel-embedded, hydrogel-based, air-liquid interface) tailored to specific research needs.

By Disease

By Types

By Sources

Workflow for Molecular Biology Research

Consultation & Project Design: Collaborative establishment of research objectives, selection of organoid models, and definition of the optimal molecular analysis pipeline.
Organoid Culture & Treatment: Generation, expansion, and required experimental perturbation (e.g., drug treatment, genetic modification) of characterized 3D cancer organoids.
Sample Preparation & QC: Careful harvesting, lysing, and nucleic acid/protein extraction from organoids, followed by rigorous quality control assessment.
Advanced Molecular Analysis: Execution of the agreed-upon assays (sequencing, arrays, mass spectrometry) on dedicated platforms.
Bioinformatics & Data Integration: Primary data processing, advanced bioinformatic analysis, and integration with phenotypic data.
Reporting & Consultation: Delivery of a comprehensive report with interpreted results, actionable insights, and expert discussion on findings and next steps.

Customized Solutions for Molecular Biology Research

Alfa Cytology's service portfolio encompasses the full spectrum of modern molecular techniques, each optimized for the 3D organoid context to deliver deep mechanistic insights.

Genetic Analysis

Comprehensive genomic profiling via next-generation sequencing (NGS), including whole exome sequencing (WES), targeted cancer panel sequencing, and SNP/CNV analysis to identify driver mutations, copy number variations, and structural variants.

Epigenetic Analysis

Interrogation of DNA methylation patterns using bisulfite sequencing (RRBS, WGBS) and assessment of chromatin accessibility (ATAC-seq) to uncover regulatory alterations influencing gene expression in tumor organoids.

Protein & Signaling Analysis

Utilizing advanced mass spectrometry (LC-MS/MS) and automated western blotting to quantify protein expression and phosphorylation states, providing a real-time snapshot of active signaling hubs like MAPK, PI3K/AKT, and Wnt pathways.

Non-Coding RNA Analysis

Profiling of microRNA (miRNA) and long non-coding RNA (lncRNA) expression through NGS to discover regulatory networks governing oncogenesis, metastasis, and therapeutic response in the 3D context.

Key Analyses of Molecular Biology Research

Beyond data generation, our bioinformatics expertise transforms raw data into biological understanding through advanced downstream analyses, including:

Somatic Variant Calling & Annotation

Identification and functional interpretation of single-nucleotide variants (SNVs), indels, and copy number alterations from sequencing data.

Differential Gene Expression Analysis

Statistical comparison of transcriptome profiles (coding and non-coding RNA) between experimental conditions to identify significantly upregulated or downregulated genes and pathways.

Pathway Enrichment & Network Analysis

Utilization of specialized tools to determine biological pathways, molecular networks, and functional ontologies most affected in the studied organoid models.

Clonal Evolution Tracking

Monitoring genetic shifts over time or under selective pressure within the organoid population provides insights into resistance mechanisms and disease progression.

Case Study-Deciphering Chemoresistance Mechanisms in Pancreatic Cancer Organoids Through Integrated Pharmacogenomics

Alfa Cytology developed the patient-derived pancreatic cancer organoid model to investigate mechanisms of chemotherapy resistance and identify novel therapeutic strategies. Pharmacogenomic profiling was performed on organoids stratified by their response to standard chemotherapeutics. This analysis revealed a distinct molecular signature in chemoresistant models, characterized by significant enrichment of protein glycosylation and cholesterol metabolism pathways. Subsequent high-throughput drug screening identified a class of metabolic-targeting agents as selectively potent against the resistant cohort. Validation studies in expanded organoid sets confirmed the synergistic effect of combining these agents with first-line chemotherapy, significantly restoring therapy sensitivity. Mechanistic investigation demonstrated that the therapy attenuated the identified metabolic pathways and concurrently suppressed the epithelial-to-mesenchymal transition (EMT) signature, a key driver of resistance. These results exemplified how our integrated molecular biology services can decipher resistance mechanisms and uncover effective combination therapies within a physiologically relevant model system.

Treatment with the tested inhibitors led to a significant reduction in EMT signature gene expression. Fig.1 The tested inhibitors were effective in suppressing the expression of genes associated with EMT. Data are presented as mean ± SEM (n=3; **p < 0.01).

Why Choose Us?

Integrated Solution: Seamlessly integrating advanced 3D organoid biology with cutting-edge molecular analysis for end-to-end, physiologically relevant insights.
Customized Service: Designing fully customized service packages, from model selection to bioinformatic depth, to directly match your specific research objectives.
Precision and Reproducibility: Implementing stringent quality control at every stage to ensure the highest data integrity, reproducibility, and reliability.
Collaborative Scientific Support: Providing end-to-end expert collaboration and insightful interpretation, transforming complex data into reliable scientific understanding.

Contact Us

Alfa Cytology is committed to advancing your cancer research by providing sophisticated molecular biology services intrinsically linked to the physiological relevance of 3D cancer organoid models. From foundational genetic characterization to complex multi-omic integration, our team delivers the precise, high-quality data and insights needed to accelerate discovery and therapeutic development. Contact us to discuss how we can customize a molecular biology research program to power your specific project goals.

Reference

Zhao, Hua et al. "Investigation of early neoplastic transformation and premalignant biology using genetically engineered organoid models." Computational and structural biotechnology journal 20 (2022): 5309-5315.

For research use only.